Pharmacelera

📍 Barcelona, Spain🗓 Founded 2015👥 28 employees💰 Last funded Feb 2026
Software Development🌐 pharmacelera.com
Website LinkedIn
Quantum-Mechanics and Machine Learning Drug Discovery. Pharmacelera develops proprietary Computer-Aided Drug Design software and provides access to its technology through flexible licensing options and computational chemistry services. The methodology mines an unexploited chemical space, finding starting points with larger chemical diversity and improving the creativity of chemists. The technology is based on accurate Quantum-Mechanics algorithms, Machine Learning and High-Performance Computing (HPC) and it derives from more than 25 years of research. Pharmacelera helps companies in Target Identification, Hit-Identification, Hit-to-Lead and Lead Optimization drug discovery stages by finding novel hits, improving ligand binding properties (ADME, Tox, ...), obtaining insights of ligand / receptor interactions and identifying original backup compounds. Learn more on how to de-risk your drug discovery project by emailing us at contact@pharmacelera.com or by visiting our webpage at www.pharmacelera.com
4
Total investors
1
Early stage
1
Mid stage
1
Late stage
2015
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Spain
2
Switzerland
1
Belgium
1
Investor activity2016–2026 · investors recorded per year
20161201912021120261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Pharmacelera?
Pharmacelera has 4 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Pharmacelera last raise funding?
The most recent investment in Pharmacelera recorded on gritt.io was in February 2026.
When was Pharmacelera founded?
Pharmacelera was founded in 2015.
What industry is Pharmacelera in?
Pharmacelera operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Pharmacelera based?
Pharmacelera is headquartered in Barcelona, Spain.